HFE gene variants modify the association between maternal lead burden and infant birthweight: A prospective birth cohort study in Mexico City, Mexico

Environmental Health: A Global Access Science Source

Volumn 9, Issue 1, 2010, Pages

  Cantonwine, David ^a   Hu, Howard ^a,b,c   Téllez Rojo, Martha ^d   Sánchez, Brisa N ^a   Lamadrid Figueroa, Héctor ^d   Ettinger, Adrienne S ^b,c   Mercado García, Adriana ^d   Hernández Avila, Mauricio ^e   Wright, Robert O ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e Ministry of Health   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; TRANSFERRIN;

BLOOD; COHORT ANALYSIS; ENVIRONMENTAL FACTOR; GENETIC VARIATION; GENOTYPE; LEAD; MATERNAL HEALTH; METABOLISM; POLYMORPHISM; REGRESSION ANALYSIS; TOXICITY;

ADULT; ARTICLE; BIRTH WEIGHT; BODY BURDEN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FUNCTION; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HFE GENE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; PROSPECTIVE STUDY; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; HEMOCHROMATOSIS; METABOLISM; NEWBORN; PREGNANCY;

FEDERAL DISTRICT [MEXICO]; MEXICO [NORTH AMERICA]; MEXICO CITY;

BIRTH WEIGHT; BODY BURDEN; COHORT STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFANT, NEWBORN; IRON; LEAD; MEMBRANE PROTEINS; MEXICO; POLYMORPHISM, GENETIC; PREGNANCY; PROSPECTIVE STUDIES; TRANSFERRIN;

EID: 77954873185     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-9-43     Document Type: Article

References (55)

1. Birthweight and cognitive development during childhood. Tong S, Baghurst P, McMichael A, J Paediatr Child Health 2006 42 98 103 10.1111/j.1440-1754.2006. 00805.x 16509907 (Pubitemid 43356861)
2. Nutrition and low birth weight: from research to practice. Ramakrishnan U, Am J Clin Nutr 2004 79 17 21 14684392 (Pubitemid 41132057)
3. Brain development during fetal life: influences of the intra-uterine environment. Rees S, Harding R, Neuroscience letters 2004 361 111 114 10.1016/j.neulet.2004.02.002 15135906 (Pubitemid 38609229)
4. Decrease in birth weight in relation to maternal bone-lead burden. Gonzalez-Cossio T, Peterson KE, Sanin LH, Fishbein E, Palazuelos E, Aro A, Hernandez-Avila M, Hu H, Pediatrics 1997 100 856 862 10.1542/peds.100.5.856 9346987 (Pubitemid 27463323)
5. Genetic and Environmental Influences on Birth Weight, Birth Length, Head Circumference, and Gestational Age by Use of Population-based Parent-Offspring Data. Lunde A, Melve KK, Gjessing HK, Skjaerven R, Irgens LM, Am J Epidemiol 2007 165 7 734 41 10.1093/aje/kwk107 17311798 (Pubitemid 46434610)
6. Genetic variations and normal fetal growth. Dunger DB, Petry CJ, Ong KK, Horm Res 2006 65 34 40 10.1159/000091504 16612112 (Pubitemid 44689431)
7. Child development: risk factors for adverse outcomes in developing countries. Walker SP, Wachs TD, Gardner JM, Lozoff B, Wasserman GA, Pollitt E, Carter JA, Lancet 2007 369 145 157 10.1016/S0140-6736(07)60076-2 17223478 (Pubitemid 46073134)
8. Assessing the Iron Status of Populations. WHO C, Organization WH. Geneva: WHO/CDC Joint Report 2004
9. Effect of magnitude and timing of maternal pregnancy blood lead (Pb) levels on birth outcomes. Jelliffe-Pawlowski LL, Miles SQ, Courtney JG, Materna B, Charlton V, Journal of Perinatology 2006 26 154 162 10.1038/sj.jp.7211453 16453008
10. Iron deficiency and brain development. Lozoff B, Georgieff MK, Semin Pediatr Neurol 2006 13 158 165 10.1016/j.spen.2006.08.004 17101454 (Pubitemid 44712046)
11. Iron and pregnancy - a delicate balance. Milman N, Ann Hematol 2006 85 559 565 10.1007/s00277-006-0108-2 16691399 (Pubitemid 44283075)
12. Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic. Wright RO, Tsaih SW, Schwartz J, Wright RJ, Hu H, J Pediatr 2003 142 9 14 10.1067/mpd.2003.mpd0344 12520247 (Pubitemid 36106380)
13. Effects of iron therapy on infant blood lead levels. Wolf AW, Jimenez E, Lozoff B, J Pediatr 2003 143 789 795 10.1067/S0022-3476(03)00540-7 14657829 (Pubitemid 37510651)
14. Association of ferroportin Q248 H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Rivers CA, Barton JC, Gordeuk VR, Acton RT, Speechley MR, Snively BM, Leiendecker-Foster C, Press RD, Adams PC, McLaren GD, et al. Blood Cells, Molecules, and Diseases 2007 38 247 252 10.1016/j.bcmd.2006.12.002 (Pubitemid 46533939)
15. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Hanson EH, Imperatore G, Burke W, Am J Epidemiol 2001 154 193 206 10.1093/aje/154.3.193 11479183 (Pubitemid 32701154)
16. Genetic susceptibility to lead poisoning. Onalaja AO, Claudio L, Environmental Health Perspectives 2000 108 23 28 10.2307/3454630 10698721 (Pubitemid 30168693)
17. Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline. Wang FT, Hu H, Schwartz J, Weuve J, Spiro AS, Sparrow D, Nie H, Silverman EK, Weiss ST, Wright RO, Environ Health Perspect 2007 115 1210 1215 10.1289/ehp.9855 17687449 (Pubitemid 351802354)
18. Association between hemochromatosis genotype and lead exposure among elderly men: the normative aging study. Wright RO, Silverman EK, Schwartz J, Tsaih SW, Senter J, Sparrow D, Weiss ST, Aro A, Hu H, Environ Health Perspect 2004 112 746 750 10.1289/ehp.6581 15121519 (Pubitemid 38628405)
19. Variants in iron metabolism genes predict higher blood lead levels in young children. Hopkins MR, Ettinger AS, Hernandez-Avila M, Schwartz J, Tellez-Rojo MM, Lamadrid-Figueroa H, Bellinger D, Hu H, Wright RO, Environ Health Perspect 2008 116 1261 1266 10.1289/ehp.11233 18795173
20. Dietary calcium supplements to lower blood lead levels in lactating women: a randomized placebo-controlled trial. Hernandez-Avila M, Gonzalez-Cossio T, Hernandez-Avila JE, Romieu I, Peterson KE, Aro A, Palazuelos E, Hu H, Epidemiology 2003 14 206 212 10.1097/00001648-200303000-00015 12606887 (Pubitemid 40417108)
21. [Standardization of quantitative epidemiological methods in the field]. Habicht JP, Boletin de la Oficina Sanitaria Panamericana 1974 76 375 384 4277063
22. Anthropometric standarization reference manual. Lohman, Roche, Martorell, Human Kinetics Book Champaign: Human Kinetics Publishers 1988
23. Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. Aro AC, Todd AC, Amarasiriwardena C, Hu H, Physics in medicine and biology 1994 39 2263 2271 10.1088/0031-9155/39/12/009 15551552 (Pubitemid 24363473)
24. Percentage Points for a Generalized ESD Many-Outlier Procedure. Rosner B, Technometrics 1983 25 165 172 10.2307/1268549 (Pubitemid 13540616)
25. Recommendations to prevent and control iron deficiency in the United States. CDC, MMWR Recomm Rep 1998 47 1 29
26. HFE gene mutation and transferrin saturation in very low birthweight infants. Maier RF, Witt H, Buhrer C, Monch E, Kottgen E, Archives of disease in childhood 1999 81 144 145 10448186
27. Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells. Bannon D, Portnoy ME, Olivi L, Lees PS, Culotta VC, Bressler JP, Biochem Biophys Res Commun 2002 295 978 984 10.1016/S0006-291X(02)00756-8 12127992
28. Divalent metal transporter 1 in lead and cadmium transport. Bressler JP, Olivi L, Cheong JH, Kim Y, Bannona D, Annals of the New York Academy of Sciences 2004 1012 142 152 10.1196/annals.1306.011 15105261 (Pubitemid 38453521)
29. Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Georgieff MK, Wobken JK, Welle J, Burdo JR, Connor JR, Placenta 2000 21 8 799 804 10.1053/plac.2000.0566 11095929
30. Transferrin receptor co-localizes and interacts with the hemochromatosis factor (HFE) and the divalent metal transporter-1 (DMT1) in trophoblast cells. Gruper Y, Bar J, Bacharach E, Ehrlich R, J Cell Physiol 2005 204 901 912 10.1002/jcp.20349 15880641 (Pubitemid 41099276)
31. Localisation of proteins of iron metabolism in the human placenta and liver. Bastin J, Drakesmith H, Rees M, Sargent I, Townsend A, Br J Haematol 2006 134 532 543 10.1111/j.1365-2141.2006.06216.x 16856887 (Pubitemid 44141720)
32. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, Fleming RE, Sly WS, Proc Natl Acad Sci USA 1997 94 13198 13202 10.1073/pnas.94.24.13198 9371823 (Pubitemid 27518499)
33. Molecular control of iron transport. Ganz T, J Am Soc Nephrol 2007 18 394 400 10.1681/ASN.2006070802 17229910 (Pubitemid 46193304)
34. DMT1: a mammalian transporter for multiple metals. Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, Moore EG, Hainsworth LN, Umbreit JN, Conrad ME, et al. Biometals 2003 16 1 41 54 10.1023/A:1020702213099 12572663 (Pubitemid 36140214)
35. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Fleming RE, Migas MC, Zhou X, Jiang J, Britton RS, Brunt EM, Tomatsu S, Waheed A, Bacon BR, Sly WS, Proc Natl Acad Sci USA 1999 96 3143 3148 10.1073/pnas.96.6.3143 10077651 (Pubitemid 29148858)
36. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Zoller H, Koch RO, Theurl I, Obrist P, Pietrangelo A, Montosi G, Haile DJ, Vogel W, Weiss G, Gastroenterology 2001 120 1412 1419 10.1053/gast.2001.24033 11313311 (Pubitemid 32322315)
37. Intestinal expression of genes involved in iron absorption in humans. Rolfs A, Bonkovsky HL, Kohlroser JG, McNeal K, Sharma A, Berger UV, Hediger MA, Am J Physiol Gastrointest Liver Physiol 2002 282 598 607 11897618
38. Iron and oxidative stress in pregnancy. Casanueva E, Viteri FE, Journal of Nutrition 2003 133 1700S 1708S 12730487 (Pubitemid 36548678)
39. Maternal hemoglobin and serum albumin and fetal growth. Swain S, Singh S, Bhatia BD, Pandey S, Krishna M, Indian pediatrics 1994 31 777 782 7890339
40. Preconception hemoglobin and ferritin concentrations are associated with pregnancy outcome in a prospective cohort of Chinese women. Ronnenberg AG, Wood RJ, Wang X, Xing H, Chen C, Chen D, Guang W, Huang A, Wang L, Xu X, The Journal of nutrition 2004 134 2586 2591 15465752 (Pubitemid 39315259)
41. Iron status and its association with pregnancy outcome in Korean pregnant women. Lee HS, Kim MS, Kim MH, Kim YJ, Kim WY, European journal of clinical nutrition 2006 60 1130 1135 10.1038/sj.ejcn.1602429 16639418 (Pubitemid 44340413)
42. Third trimester iron status and pregnancy outcome in non-anaemic women; pregnancy unfavourably affected by maternal iron excess. Lao TT, Tam KF, Chan LY, Hum Reprod 2000 15 1843 1848 10.1093/humrep/15.8.1843 10920115 (Pubitemid 30636081)
43. Effect of early maternal iron stores on placental weight and structure. Hindmarsh PC, Geary MP, Rodeck CH, Jackson MR, Kingdom JC, Lancet 2000 356 719 723 10.1016/S0140-6736(00)02630-1 11085691 (Pubitemid 30663241)
44. The influence of maternal haemoglobin and ferritin on mid-pregnancy placental volume. Howe DT, Wheeler T, Osmond C, Br J Obstet Gynaecol 1995 102 213 219 7794845
45. Increased fetoplacental angiogenesis during first trimester in anaemic women. Kadyrov M, Kosanke G, Kingdom J, Kaufmann P, Lancet 1998 352 1747 1749 10.1016/S0140-6736(98)02069-8 9848351 (Pubitemid 28534958)
46. Fetal growth in maternal anaemia. Singla PN, Tyagi M, Kumar A, Dash D, Shankar R, J Trop Pediatr 1997 43 89 92 10.1093/tropej/43.2.89 9143178 (Pubitemid 27183089)
47. Chronic exposure to high levels of dietary iron fortification increases lipid peroxidation in the mucosa of the rat large intestine. Lund EK, Fairweather-Tait SJ, Wharf SG, Johnson IT, The Journal of nutrition 2001 131 2928 2931 11694620 (Pubitemid 33063125)
48. Oral repletion of iron induces free radical mediated alterations in the gastrointestinal tract of rat. Srigiridhar K, Nair KM, Subramanian R, Singotamu L, Molecular and cellular biochemistry 2001 219 91 98 10.1023/A:1011023111048 11354259 (Pubitemid 32331449)
49. Free radical-mediated pre-hemolytic injury in human red blood cells subjected to lead acetate as evaluated by chemiluminescence. Casado MF, Cecchini AL, Simao AN, Oliveira RD, Cecchini R, Food Chem Toxicol 2007 45 945 952 10.1016/j.fct.2006.12.001 17250942 (Pubitemid 46509815)
50. Prominent free radicals scavenging activity of tannic acid in lead-induced oxidative stress in experimental mice. El-Sayed IH, Lotfy M, El-Khawaga OA, Nasif WA, El-Shahat M, Toxicology and industrial health 2006 22 157 163 10.1191/0748233706th256oa 16786837 (Pubitemid 43844669)
51. Association of combined maternal-fetal TNF-alpha gene G308A genotypes with preterm delivery: a gene-gene interaction study. Liang M, Wang X, Li J, Yang F, Fang Z, Wang L, Hu Y, Chen D, J Biomed Biotechnol 2010 396184 20224765
52. Low organic solvent exposure and combined maternal-infant gene polymorphisms affect gestational age. Qin X, Wu Y, Wang W, Liu T, Wang L, Hu Y, Chen D, Occup Environ Med 2008 65 482 487 10.1136/oem.2007.032474 18070799 (Pubitemid 351969698)
53. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, Tawn EJ, Burn J, Journal of medical genetics 2004 41 256 260 10.1136/jmg.2003.010694 15060097 (Pubitemid 38496767)
54. Possible gene-gene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia. Tan CY, Chong YS, Loganath A, Chan YH, Ravichandran J, Lee CG, Chong SS, Reprod Sci 2009 16 1135 1143 10.1177/1933719109342280 19700612
55. HFE mutations, iron deficiency and overload in 10,500 blood donors. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M, Br J Haematol 2001 114 474 484 10.1046/j.1365-2141.2001.02949.x 11529872 (Pubitemid 32762252)